| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |